Individuals aged 1-64 years with documented congenital heart defects at healthcare encounters, five U.S. surveillance sites, 2011-2013 - 19/06/21
, Sherry L. Farr, PhD a, Wendy M. Book, MD b, Lorenzo Botto, MD c, Jennifer S. Li, MD, MHS d, Aida S. Soim, PhD, MD e, Karrie F. Downing, MPH a, Tiffany Riehle-Colarusso, MD, MPH f, Alfred A D'Ottavio, BSE, BEE d, Marcia L. Feldkamp, PhD c, Amber D. Khanna, MS, MD g, Cheryl L. Raskind-Hood, MS, MPH b, Kristin M. Sommerhalter, PhD e, Tessa L Crume, MS, PhD hRésumé |
Background |
Many individuals born with congenital heart defects (CHD) survive to adulthood. However, population estimates of CHD beyond early childhood are limited in the U.S.
Objectives |
To estimate the percentage of individuals aged 1-to-64 years at five U.S. sites with CHD documented at a healthcare encounter during a three-year period and describe their characteristics.
Methods |
Sites conducted population-based surveillance of CHD among 1 to 10-year-olds (three sites) and 11 to 64-year-olds (all five sites) by linking healthcare data. Eligible cases resided in the population catchment areas and had one or more healthcare encounters during the surveillance period (January 1, 2011-December 31, 2013) with a CHD-related ICD-9-CM code. Site-specific population census estimates from the same age groups and time period were used to assess percentage of individuals in the catchment area with a CHD-related ICD-9-CM code documented at a healthcare encounter (hereafter referred to as CHD cases). Severe and non-severe CHD were based on an established mutually exclusive anatomic hierarchy.
Results |
Among 42,646 CHD cases, 23.7% had severe CHD and 51.5% were male. Percentage of CHD cases among 1 to 10-year-olds, was 6.36/1,000 (range: 4.33-9.96/1,000) but varied by CHD severity [severe: 1.56/1,000 (range: 1.04-2.64/1,000); non-severe: 4.80/1,000 (range: 3.28-7.32/1,000)]. Percentage of cases across all sites in 11 to 64-year-olds was 1.47/1,000 (range: 1.02-2.18/1,000) and varied by CHD severity [severe: 0.34/1,000 (range: 0.26-0.49/1,000); non-severe: 1.13/1,000 (range: 0.76-1.69/1,000)]. Percentage of CHD cases decreased with age until 20 to 44 years and, for non-severe CHD only, increased slightly for ages 45 to 64 years.
Conclusion |
CHD cases varied by site, CHD severity, and age. These findings will inform planning for the needs of this growing population.
Le texte complet de cet article est disponible en PDF.Abbreviations : ASD, CHD, ICD-9-CM, PFO, CO, GA, NC, NY, UT
Plan
Vol 238
P. 100-108 - août 2021 Retour au numéro
Article précédent
- Long-term prognostic outcomes and implication of oral anticoagulants in patients with new-onset atrial fibrillation following st-segment elevation myocardial infarction
- Jasmine Melissa Madsen, Mia Ravn Jacobsen, Muhammad Sabbah, Divan Gabriel Topal, Reza Jabbari, Charlotte Glinge, Lars Køber, Christian Torp-Pedersen, Frants Pedersen, Rikke Sørensen, Lene Holmvang, Thomas Engstrøm, Jacob Thomsen Lønborg
- Validity of different dose reduction criteria for apixaban
- Nathaniel M. Hawkins, Lee Er, Roopinder K. Sandhu, Padma Kaul, Finlay A. McAlister, Adeera Levin, Jason G. Andrade
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?